The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients

Author： de Jonge Hylke   Metalidis Christoph   Naesens Maarten   Lambrechts Diether   Kuypers Dirk RJ  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.9, 2011-09, pp. : 1281-1291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients

By Glowacki François   Lionet Arnaud  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 451-459

Adis International

Access to resources Recommend Favorite

Influence of Cytochrome P450 (CYP) 3A5 Polymorphisms on the Pharmacokinetics of Lansoprazole Enantiomers in CYP2C19 Extensive Metaboliser Renal Transplant Recipients

By Miura Masatomo  

Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism

By de Jonge Hylke   de Loor Henriette   Verbeke Krisitin   Vanrenterghem Yves   Kuypers Dirk RJ  

Pharmacogenomics, Vol. 14, Iss. 12, 2013-09 ,pp. : 1467-1480

Future Medicine

Access to resources Recommend Favorite

Amlodipine/tacrolimus interaction: Acute renal failure in a patient with diarrhoea, CYP3A5 deficiency and decreased P-gp transport activity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism

By Durand Philippe   Debray Dominique   Kolaci Mikaela   Bouligand Jerome   Furlan Valérie   Fabre Monique   Letierce Alexia   Verstuyft Céline   Becquemont Laurent  

Pharmacogenomics, Vol. 14, Iss. 9, 2013-07 ,pp. : 1017-1025

Future Medicine

Access to resources Recommend Favorite